Leading the way and creating world leaders
The mission of the David Geffen School of Medicine at UCLA is to improve health and healthcare by creating world leaders in health and science.
The David Geffen School of Medicine at UCLA is one of the premier research and educational institutions in the nation. Our dedicated faculty is committed to providing excellence in teaching our trainees who are pursuing their careers in medicine and in the biomedical sciences. Our research scientists regularly make important new advances that benefit patients, worldwide, and society, in general.
1961 - 1963
The CT Scan
William Oldendorf establishes the bedrock of computerized tomography.
Paul Terasaki develops a tissue test that transforms organ transplantation.
Michael Phelps and Edward Hoffman create UCLA’s first clinical PET center.
UCLA physicians report and describe the first cases of AIDS.
Landmark leukemia drug
Owen Witte pinpoints a genetic target crucial to the development of life-saving drugs.
Genetic basis of disease
Michael Grunstein demonstrates that histones influence gene expression and disease development.
Brain aneurysm treatment
Guido Guglielmi invents detachable coils that stop deadly bleeding from brain aneurysms.
Metabolic genetic origin
Elizabeth Neufeld receives the National Medal of Science for research critical to treating metabolic disorders.
Precision cancer treatment
Dennis Slamon characterizes an oncogene, the target for a breakthrough breast-cancer therapy.
Lou Ignarro receives the Nobel Prize in Physiology or Medicine for demonstrating the signaling properties of nitric oxide.
2004 - 2010
Prostate cancer treatment
Charles Sawyer and Michael Jung develop a drug to fight castration-resistant prostate cancer.
David Eisenberg’s model of amyloid fibers opens new avenues for treating neurodegenerative diseases.
Successful gene therapy
Donald Kohn cures “Bubble Baby” disease using gene therapy.